| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B9ZZG9 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB10; | NULL | 266 | medaka |
| B9ZZI8 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB8; | NULL | 249 | medaka |
| B9ZZF5 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB10; | NULL | 266 | medaka |
| B9ZZE6 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB8; | NULL | 251 | medaka |
| B9ZZH0 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB8; | NULL | 252 | medaka |
| D2KX33 | Calmodulin; Fragment; | CaM-C; | NULL | 56 | medaka |
| Q8HLW4 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NP_739826.1; | 173 | medaka |
| B9ZZF1 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB10; | NULL | 266 | medaka |
| B9ZZH3 | Proteasome subunit beta type; EC 3.4.25.1; Fragment; | PSMB10; | NULL | 266 | medaka |
| C3V6M9 | C-type lysozyme; Uncharacterized protein; | LOC100302449; | NP_001156629.1; | 143 | medaka |
| Q2NPX2 | NADH-ubiquinone oxidoreductase chain 6; EC 1.6.5.3; | ND6; | NULL | 173 | medaka |
| B6F103 | Histone H2B; | H2B; LOC101172789; | XP_004065519.1;XP_004065540.1;XP_004065576.1;XP_004065578.1;XP_004065583.1;XP_004076083.1;XP_004076084.1;XP_004076086.1;XP_004084102.1;XP_004085096.1;XP_004085991.1; | 124 | medaka |
| Q3V636 | HoxA2a; Uncharacterized protein; | hoxA2a; LOC100301594; | XP_004073901.1; | 359 | medaka |
| Q2NPU4 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 324 | medaka |
| O42129 | Guanylate cyclase; EC 4.6.1.2; | OlGC6; | NP_001098568.1; | 1075 | medaka |
| Q8HC91 | Cytochrome b; Fragment; | cytb; Cyt b cyt b; | NULL | 380 | medaka |
| Q8HBG9 | Cytochrome b; Fragment; | cytb; | NULL | 380 | medaka |
| Q8HI63 | Cytochrome b; Fragment; | cytb; | NULL | 380 | medaka |
| F5HRH4 | MHC class I molecule, alpha chain; MHC class I molecule, alpha-chain; | Orla-UGA; | NULL | 359 | medaka |
| Q14TH5 | Metalloendopeptidase; EC 3.4.24.-; | MC6AST4; mc6ast4; | NP_001098208.1; | 280 | medaka |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |